Alterity Therapeutics Statistics
Total Valuation
ATHE has a market cap or net worth of $21.05 million. The enterprise value is $13.09 million.
| Market Cap | 21.05M |
| Enterprise Value | 13.09M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ATHE has 9.88 million shares outstanding.
| Shares Outstanding | 9.88M |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.00% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.85 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.90, with zero debt.
| Current Ratio | 4.90 |
| Quick Ratio | 4.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.70% and return on invested capital (ROIC) is -95.16%.
| Return on Equity (ROE) | -53.70% |
| Return on Assets (ROA) | -44.20% |
| Return on Capital (ROIC) | -95.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$759,540 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATHE has paid $361 in taxes.
| Income Tax | 361 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.87% in the last 52 weeks. The beta is 0.77, so ATHE's price volatility has been lower than the market average.
| Beta (1Y) | 0.77 |
| 52-Week Price Change | -24.87% |
| 50-Day Moving Average | 1.93 |
| 200-Day Moving Average | 2.36 |
| Relative Strength Index (RSI) | 52.16 |
| Average Volume (30 Days) | 81,164 |
Short Selling Information
| Short Interest | 23,055 |
| Short Previous Month | 26,389 |
| Short % of Shares Out | 2.25% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.77 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.84M |
| Pretax Income | -7.94M |
| Net Income | -8.35M |
| EBITDA | n/a |
| EBIT | -7.94M |
| Earnings Per Share (EPS) | -$2.21 |
Balance Sheet
The company has $7.96 million in cash and no debt, giving a net cash position of $7.96 million or $0.81 per share.
| Cash & Cash Equivalents | 7.96M |
| Total Debt | n/a |
| Net Cash | 7.96M |
| Net Cash Per Share | $0.81 |
| Equity / Book Value | 11.39M |
| Book Value Per Share | 1.15 |
| Working Capital | 11.31M |
Cash Flow
In the last 12 months, operating cash flow was -$9.44 million and capital expenditures -$5,270, giving a free cash flow of -$9.44 million.
| Operating Cash Flow | -9.44M |
| Capital Expenditures | -5,270 |
| Free Cash Flow | -9.44M |
| FCF Per Share | -$2.32 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATHE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.08% |
| Shareholder Yield | -17.08% |
| Earnings Yield | -39.68% |
| FCF Yield | -44.85% |
Analyst Forecast
The average price target for ATHE is $7.00, which is 228.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 228.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 9, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 9, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |